RHÖN-KLINIKUM Aktiengesellschaft
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of RHÖN-KLINIKUM Aktiengesellschaft generated cash of $109,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$21,200,000 last year. Net change in cash is therefore $128,700,000.
Cash Flow
| 2014 | 49.2M | 2.86B | -2.33B |
|---|---|---|---|
| 2015 | 76M | -400.5M | -227.5M |
| 2016 | 110.9M | 24.1M | -197.5M |
| 2017 | 80.9M | -3.5M | -35.7M |
| 2018 | 49.8M | -125.3M | 85.3M |
| 2019 | 47.3M | -86.7M | 35.1M |
| 2020 | 113.3M | -135.2M | -15.1M |
| 2021 | 97.5M | -58.3M | -3.9M |
| 2022 | 41.3M | -86.2M | -4.1M |
| 2023 | 109M | 40.9M | -21.2M |
RKAGY Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 77.3M | 126.3M | 91M | 128M | 132.3M | 122.45M | 265.89M | 143.3M | 695.3M | 116.8M |
Operating activities | ||||||||||
Net income | 38.71M | 33.6M | 27.4M | 3.9M | 54.2M | 48.99M | 35.15M | 56.4M | 85.4M | 1.24B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 65.6M | 69.6M | 70.2M | 69.8M | 68.1M | 60.5M | 58.92M | 59.8M | 61.1M | 82.3M |
Stock-based compensation expense | 0 | 0 | 0 | 100K | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 100K | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -900K | -15.7M | -18.9M | 32.7M | -11.2M | -9M | -12.9M | -12.6M | -6M | -10M |
Inventories | -900K | -200K | 2.1M | -6.8M | -2.2M | -900K | -200K | -1.3M | -1.3M | 300K |
Accounts payable | -200K | 2.6M | -2.4M | 10.6M | -5.7M | -15.7M | 7.9M | 2.2M | -2.1M | 0 |
Cash generated by operating activities | 109M | 41.3M | 97.5M | 113.3M | 47.3M | 49.8M | 80.9M | 110.9M | 76M | 49.2M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -53M | 400K | -57M | -2.2M | -1M | -3M | -18.7M | -10.1M | 0 |
Investments In Property Plant And Equipment | -62.8M | -58.2M | -77.8M | -97M | -114.5M | -163.4M | -115.8M | -113.5M | -76.4M | -93.9M |
Acquisitions Net | -200K | -300K | -400K | -6M | -3.4M | 1.6M | -299.99K | 800K | 43.4M | 2.94B |
Cash generated by investing activities | 40.9M | -86.2M | -58.3M | -135.2M | -86.7M | -125.3M | -3.5M | 24.1M | -400.5M | 2.86B |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | -10M | 0 | 0 | 0 | -19.4M | -14.7M | -23.4M | -53.6M | -58.8M | -34.6M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -167M | -1.63B |
Repayments of term debt | -7M | 0 | -3.5M | -10M | 59M | -101.2M | -10.8M | -143.8M | 0 | -603.9M |
Cash used in financing activities | -21.2M | -4.1M | -3.9M | -15.1M | 35.1M | 85.3M | -35.7M | -197.5M | -227.5M | -2.33B |
Net Change In Cash | 128.7M | -49M | 35.3M | -37M | -4.3M | 9.83M | -143.44M | 122.59M | -207M | 578.5M |
Cash at end of period | 206M | 77.3M | 126.3M | 91M | 128M | 132.28M | 122.45M | 265.89M | 488.3M | 695.3M |